Kernex Microsystems (India) Limited sees a credit rating action
TL;DR
What specific financial or operational drivers did CARE Ratings cite in their latest rationale for the upgrade, and how do these align with the company's reported debt-to-equity ratio and interest coverage metrics in the most recent quarterly filings?
CARE’s latest rating extract does not disclose the specific financial or operational drivers behind the upgrade. It records the rating action: long-term facilities were upgraded from CARE BBB- to CARE BBB with Stable outlook, short-term ratings from CARE A3 to CARE A3+, and facilities were enhanced from Rs 100 Crores to Rs 125 Crores and from Rs 175 Crores to Rs 525 Crores; a new Rs 10 Crores term loan was also rated CARE BBB Stable. [1]
Alignment with the latest quarterly metrics
Analyst read: the reported numbers are more consistent with an upgrade supported by stronger operating earnings and debt-servicing capacity than by deleveraging. Q1 FY27 interest coverage of 12.34x was substantially above 8.99x in Q4 FY26 and 5.07x in Q1 FY26, while debt-to-equity remained at 0.65x, unchanged from Q4 FY26 and above 0.26x a year earlier. [7] [6] [5] [4] [3] [2]
The key limitation is attribution: the cited CARE material confirms the upgraded ratings and larger sanctioned facilities, but does not state whether CARE specifically relied on revenue growth, order execution, profitability, liquidity, customer concentration, or project visibility. Those would be in the full CARE rationale, which is not reproduced in the cited extract.
| Metric | Q1 FY26 | Q4 FY26 | Q1 FY27 | Read-through |
|---|---|---|---|---|
| Debt-to-equity | 0.26x [2] | 0.65x [3] | 0.65x [4] | Leverage remained elevated versus the prior-year quarter and did not improve sequentially |
| Interest coverage | 5.07x [5] | 8.99x [6] | 12.34x [7] | Material improvement in earnings capacity relative to finance costs |
| Total debt | Rs 40.32 Crores [8] | Rs 162.11 Crores [9] | Rs 162.11 Crores [10] | Debt was flat sequentially but substantially higher year on year |
| EBITDA | Rs 12.94 Crores [11] | Rs 106.04 Crores [12] | Rs 163.31 Crores [13] | Strong operating-profit scale-up supports coverage |
How does the upgraded credit rating impact the company's cost of borrowing, specifically regarding the interest rates on existing working capital facilities and term loans as disclosed in the latest Annual Report or Notes to Accounts?
The rating upgrade is credit-positive but does not, by itself, establish that Kernex’s existing borrowing rates have already fallen. It should improve negotiating leverage and may reduce the spread charged on new, renewed, or repriced facilities; however, no old-versus-new interest rate or quantified interest saving is disclosed.
- CARE upgraded the rating on the Rs 525 Crore long-term bank facility from CARE BBB-; Stable to CARE BBB; Stable. The long-term/short-term facility of Rs 125 Crore was upgraded from CARE BBB-; Stable / CARE A3 to CARE BBB; Stable / CARE A3+. A further Rs 10 Crore long-term facility was assigned CARE BBB; Stable [14].
- CARE’s facility-level annexure identifies the Rs 525 Crore facility as fund-based long-term cash credit, and the Rs 10 Crore facility as a fund-based long-term term loan. The coupon-rate field is shown as “–”, so the applicable interest rates are not reported there [1].
- The rating disclosure also does not state that the contractual interest rate on the existing cash-credit or term-loan facilities has been reset. Therefore, the immediate benefit is best viewed as potential future interest-cost reduction, rather than a reported reduction in the current finance cost.
Implication: the upgrade from BBB- to BBB and from A3 to A3+ should support a lower risk premium when facilities are sanctioned, renewed, refinanced, or repriced. The actual effect on existing working-capital facilities and term loans depends on whether their loan agreements link pricing to external ratings or allow repricing by the lender. The latest cited material does not disclose that linkage, the applicable rates, or the annual rupee saving.
Does the rating rationale highlight improvements in the company's working capital cycle or debtor days, and how do these metrics compare to the historical averages reported in the last three fiscal years?
No. The rating disclosure highlights the upgrade in CARE ratings and enhanced bank facilities, but it does not identify an improvement in the working-capital cycle or debtor days as a rating rationale [14]. The full working-capital cycle is also not reported, so it cannot be assessed without payable days and inventory days.
Debtor days trend
Receivable days are used as the closest reported proxy for debtor days.
† Derived as the arithmetic average of FY24, FY25 and FY26 receivable days.
Interpretation: Q1 FY27 receivable days were approximately 17.12% below the FY24-FY26 average, which is directionally better. However, the improvement is not yet a clear structural trend: Q1 FY27 remained materially above FY25's 23.10 days and the three-year average is distorted by the sharp increase to 144.20 days in FY26. Also, Q1 FY27 is a quarterly figure, whereas the comparison base consists of full-year figures.
Accordingly, the rating action cannot be said to have been supported by a demonstrated working-capital improvement on the disclosed evidence. The latest debtor-day reading is better than the three-year average, but the full working-capital cycle remains unquantifiable.
Sources
- [1]Kernex Microsystems (India) Limited — Careratings, 2026-10-12T00:00:00
- [2]Debt Equity Ratio
- [3]Debt Equity Ratio
- [4]Debt Equity Ratio
- [5]Interest Coverage Ratio
- [6]Interest Coverage Ratio
- [7]Interest Coverage Ratio
- [8]Total Debt
- [9]Total Debt
- [10]Total Debt
- [11]EBITDA
- [12]EBITDA
- [13]EBITDA
- [14]Kernex Microsystems Receives Upgraded Credit Ratings from CARE Ratings Limited — 2026-10-13T13:26:44.727000, p.1
- [15]TTM Receivable Days
- [16]TTM Receivable Days
- [17]TTM Receivable Days
- [18]Receivable Days
Keep digging